如果在人身上也有同样的结果出现，那么，医生们就得去找出这类抗血管新生抑制剂的最合适剂量，以及最佳的给药时间。
If such studies pan out in humans, however, physicians will need to work out the optimal dosage and timing of administration.
此外，一些血管生成抑制剂已被FDA批准作为治疗癌症或眼内新生血管性疾病。
In addition, several angiogenesis inhibitors have been approved by the FDA as therapy for cancer or intraocular neovascular disorders.
随着新生血管发病机制的深入研究，有关新生血管抑制剂的研究也越来越多。
As the mechanism of CNV further develops, more research has been undergone on the CNV inhibitors.
随着新生血管发病机制的深入研究，有关新生血管抑制剂的研究也越来越多。
As the mechanism of CNV further develops, more research has been undergone on the CNV inhibitors.
应用推荐